EUVIMEDEUVIMED entdecken
Open Access

Glioma-induced alterations in excitatory neurons are reversed by mTOR inhibition

Alexander R Goldberg, Athanassios Dovas, Daniela Torres, Brianna Pereira, Ashwin Viswanathan, Sohani Das Sharma, Angeliki Mela, Edward M Merricks, Cristina Megino-Luque, Julie J McInvale, Markel Olabarria, Leila Abrishami Shokooh und 27 weitere

Neuron · 2025-03 · 113 (6) · 858-875.e10

DOI: 10.1016/j.neuron.2024.12.026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Neuron, 2025-03. Verfasst von Alexander R Goldberg und 38 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Cell Biology, Irving Cancer Research Center, Columbia University Irving Medical Center, New York, NY 10032, USA. Hauptthemen laut MEDLINE: Glioma, TOR Serine-Threonine Kinases, Neurons, Brain Neoplasms. Die Arbeit wurde bisher 32-mal zitiert (Crossref) und nennt 136 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, NINDS NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gliomas are aggressive neoplasms that diffusely infiltrate the brain and cause neurological symptoms, including cognitive deficits and seizures. Increased mTOR signaling has been implicated in glioma-induced neuronal hyperexcitability, but the molecular and functional consequences have not been identified. Here, we show three types of changes in tumor-associated neurons: (1) downregulation of transcripts encoding excitatory and inhibitory postsynaptic proteins and dendritic spine development and upregulation of cytoskeletal transcripts via neuron-specific profiling of ribosome-bound mRNA, (2) marked decreases in dendritic spine density via light and electron microscopy, and (3) progressive functional alterations leading to neuronal hyperexcitability via in vivo calcium imaging. A single acute dose of AZD8055, a combined mTORC1/2 inhibitor, reversed these tumor-induced changes. These findings reveal mTOR-driven pathological plasticity in neurons at the infiltrative margin of glioma and suggest new strategies for treating glioma-associated neurological symptoms.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GliomaTOR Serine-Threonine KinasesNeuronsBrain NeoplasmsMTOR InhibitorsAnimalsMiceMorpholinesDendritic Spines

Stichwörter der Autor:innen

alterations in neuronal activitybrain tumor microenvironmentbrain tumorsdendritic spinesexcitatory neuronsgliomaglioma microenvironmentglioma-associated neuronal alterationsglioma-induced plasticitymTOR inhibitionneuronal hyperexcitability

Substanzen

TOR Serine-Threonine KinasesMorpholines(5-(2,4-bis((3S)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanolMTOR Inhibitors

Autor:innen und Institutionen

  • Department of Pathology and Cell Biology, Irving Cancer Research Center, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Department of Systems Biology, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Department of Neurology, Columbia University Irving Medical Center, New York, NY 10032, USA.
  • Department of Medicine, Division of Hematology and Oncology, The Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai, New York, NY 10027, USA.
  • Laboratory for Functional Optical Imaging, Zuckerman Mind Brain Behavior Institute, Departments of Biomedical Engineering and Radiology, Columbia University, New York, NY 10027, USA.
  • Department of Neurological Surgery, Columbia University Irving Medical Center, New York, NY 10032, USA.

Förderung

  • NCI NIH HHS
  • NINDS NIH HHS
  • NIGMS NIH HHS
  • American Epilepsy Society
  • National Cancer Center
  • James S McDonnell Foundation
  • Mark Foundation For Cancer Research
  • National Institute of General Medical Sciences

Zitieren

APA

Goldberg, A. R., Dovas, A., Torres, D., Pereira, B., Viswanathan, A., Das Sharma, S., Mela, A., Merricks, E. M., Megino-Luque, C., McInvale, J. J., Olabarria, M., Shokooh, L. A., Zhao, H. T., Chen, C., Kotidis, C., Calvaresi, P., Banu, M. A., Razavilar, A., Sudhakar, T. D., …, & Canoll, P. (2025). Glioma-induced alterations in excitatory neurons are reversed by mTOR inhibition. Neuron, 113(6), 858-875.e10. https://doi.org/10.1016/j.neuron.2024.12.026

Vancouver

Goldberg AR, Dovas A, Torres D, Pereira B, Viswanathan A, Das Sharma S, et al. Glioma-induced alterations in excitatory neurons are reversed by mTOR inhibition. Neuron. 2025;113(6):858-875.e10. doi:10.1016/j.neuron.2024.12.026

BibTeX
@article{Goldberg2025,
  author = {Goldberg, Alexander R and Dovas, Athanassios and Torres, Daniela and Pereira, Brianna and Viswanathan, Ashwin and Das Sharma, Sohani and Mela, Angeliki and Merricks, Edward M and Megino-Luque, Cristina and McInvale, Julie J and Olabarria, Markel and Shokooh, Leila Abrishami and Zhao, Hanzhi T and Chen, Cady and Kotidis, Corina and Calvaresi, Peter and Banu, Matei A and Razavilar, Aida and Sudhakar, Tejaswi D and Saxena, Ankita and Chokran, Cole and Humala, Nelson and Mahajan, Aayushi and Xu, Weihao and Metz, Jordan B and Bushong, Eric A and Boassa, Daniela and Ellisman, Mark H and Hillman, Elizabeth M C and Hargus, Gunnar and Bravo-Cordero, Jose Javier and McKhann, Guy M and Gill, Brian J A and Rosenfeld, Steven S and Schevon, Catherine A and Bruce, Jeffrey N and Sims, Peter A and Peterka, Darcy S and Canoll, Peter},
  title = {Glioma-induced alterations in excitatory neurons are reversed by mTOR inhibition},
  journal = {Neuron},
  year = {2025},
  volume = {113},
  number = {6},
  pages = {858--875.e10},
  doi = {10.1016/j.neuron.2024.12.026}
}
Kostenlos starten →